Clinical Takeaway
A mobile app called Minder, co-developed with university students, was tested in a randomized controlled trial to evaluate its impact on mental health and substance use outcomes in a general college population. Digital tools like this are increasingly recognized as scalable, student-friendly options for addressing the mental health challenges that commonly emerge during university years. Results from this trial provide evidence-based guidance on whether app-based interventions can meaningfully support student wellbeing at a population level.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides rigorous evidence on whether a student-codeveloped digital intervention can effectively reduce mental health and substance use symptoms during a high-risk developmental period, addressing a critical gap in scalable prevention strategies for university populations. The findings directly inform whether mobile apps represent a cost-effective, implementable alternative to traditional counseling services for institutions with limited mental health resources. Clinical adoption decisions require this level of RCT evidence to establish whether Minder meets efficacy thresholds compared to standard care or control conditions.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 This randomized controlled trial examining a student-codeveloped mobile app for mental health and substance use represents a pragmatic approach to addressing emerging problems during a vulnerable developmental period, though several limitations warrant careful interpretation. The inclusion of student voices in app design likely improved user engagement and relevance, yet the study’s effectiveness will depend heavily on actual adherence rates, which mobile interventions often struggle to maintain beyond initial adoption phases. University populations may not generalize well to broader patient populations with more severe or entrenched mental health conditions or substance use disorders, and the trial design should be scrutinized for adequate control conditions, follow-up duration, and whether reported improvements reflect meaningful clinical change or simply statistical significance in self-reported measures. As clinicians consider recommending digital tools to patients, the practical value lies in positioning such apps as adjunctive support rather than replacement therapy, identifying which student subgroups show genuine benefit, and recognizing that technology adoption alone does not guarantee clinical outcomes without concurrent attention to motivation, therapeutic alliance, and access to in-person care